Phaseline scores every recruiting and active drug trial for its likelihood of reaching approval, from open data. Oncology is free — unlock all thirteen therapeutic areas for full access.
Higher bars = better odds. Oncology and early phases are structurally the hardest.
| Approval likelihood | Est. reaction | Phase | Readout | Genetics | Area | Study | Sponsor | N | Status |
|---|
Questions, a licensing enquiry, or a trial that looks mis-scored? Send a note.
Free access covers Oncology. Full access adds every other area across all active trials.